The previous perception of GPC1 as a biomarker for prostate cancer has been challenged by recent findings that reveal its complex, paradoxical role in the regulation of prostate cancer cell proliferation and migration [57]. This evidence concerns the gene GPC1 and Familial prostate cancer.